Jeanne M. Lusher

Medicine · Health Sciences

54h-index9.8kcitations260works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Hemophilia Treatment and Research(133), Platelet Disorders and Treatments(88), Blood Coagulation and Thrombosis Mechanisms(56), Blood groups and transfusion(30), Coagulation, Bradykinin, Polyphosphates, and Angioedema(22)

Publications259 total

Ristocetin dependent cofactor activity in von Willebrand disease diagnosis: Limitations of relying on a single measure
Research and Practice in Thrombosis and Haemostasis·2022· 12 citedOpen Access
Molecular pathogenesis and heterogeneity in type 3 VWD families in U.S. Zimmerman program
Journal of Thrombosis and Haemostasis·2022· 20 citedOpen Access
Phenotypes of Allo- and Autoimmune Antibody Responses to FVIII Characterized by Surface Plasmon Resonance
UNC Libraries·2021Open Access
Laboratory variability in the diagnosis of type 2 VWD variants
Journal of Thrombosis and Haemostasis·2020· 20 citedOpen Access
Congenital and acquired disorders of coagulation
2020
Editorial Board
Haemophilia·2017Open Access
Complications of haemophilia in babies (first two years of life): a report from the Centers for Disease Control and Prevention Universal Data Collection System
Haemophilia·2016· 80 citedOpen Access
Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States
Blood·2016· 127 citedOpen Access
Coagulopathies and pediatric stroke
Journal of Pediatric Neurology·2015· 1 cited
Thromboelastography identifies children with rare bleeding disorders and predicts bleeding phenotype
Haemophilia·2014· 40 cited
Factor IX Inhibitors in Hemophilia B
2014· 3 cited
Factor VIII and IX Inhibitors in Hemophilia
2014
Treatment of hemophilia: plasma-derived clotting factors
2014
A longer acting rFVIII, safe and effective
Blood·2014
The Complete Type I VWD Cohort Of The Zimmerman Program For The Molecular and Clinical Biology Of VWD - Phenotypic Assignment, Mutation Frequency, and Bleeding Assessment
Blood·2013· 8 cited
Endogenous factor VIII synthesis from the intron 22–inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A
Nature Medicine·2013· 68 citedOpen Access
Therapeutic and prophylactic ethanol lock therapy in patients with bleeding disorders
Haemophilia·2013· 12 cited
Phenotypes of Allo- and Autoimmune Antibody Responses to FVIII Characterized by Surface Plasmon Resonance
PLoS ONE·2013· 23 citedOpen Access
No increase in bleeding identified in type 1 VWD subjects with D1472H sequence variation
Blood·2013· 34 citedOpen Access
Emergency department visits in children with hemophilia
Pediatric Blood & Cancer·2012· 13 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Indira Warrier(7), Amy D. Shapiro(7), Thomas C. Abshire(6), Steven Arkin(5), W. Keith Hoots(5), Donna DiMichele(5), Meera Chitlur(5), Louis M. Aledort(4), Margaret V. Ragni(4), Marion A. Koerper(4), Joan Cox Gill(4), Diane J. Nugent(4), Madhvi Rajpurkar(4), Richard S. Schwartz(3), Bruce M. Ewenstein(3), Nigel S. Key(3), Carol K. Kasper(3), Pier Mannuccio Mannucci(3), Roshni Kulkarni(3), Veronica H. Flood(3)